Exagen Inc (XGN)
1.40
+0.02
(+1.08%)
USD |
NASDAQ |
May 03, 16:00
1.41
+0.01
(+0.71%)
After-Hours: 20:00
Exagen Price to Book Value: 1.063 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.063 |
| May 02, 2024 | 1.052 |
| May 01, 2024 | 1.033 |
| April 30, 2024 | 1.052 |
| April 29, 2024 | 1.071 |
| April 26, 2024 | 1.072 |
| April 25, 2024 | 1.071 |
| April 24, 2024 | 1.048 |
| April 23, 2024 | 1.063 |
| April 22, 2024 | 1.063 |
| April 19, 2024 | 1.040 |
| April 18, 2024 | 1.085 |
| April 17, 2024 | 1.063 |
| April 16, 2024 | 1.090 |
| April 15, 2024 | 1.086 |
| April 12, 2024 | 1.124 |
| April 11, 2024 | 1.128 |
| April 10, 2024 | 1.116 |
| April 09, 2024 | 1.139 |
| April 08, 2024 | 1.128 |
| April 05, 2024 | 1.139 |
| April 04, 2024 | 1.154 |
| April 03, 2024 | 1.177 |
| April 02, 2024 | 1.147 |
| April 01, 2024 | 1.192 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.208 |
| March 27, 2024 | 1.185 |
| March 26, 2024 | 1.170 |
| March 25, 2024 | 1.078 |
| March 22, 2024 | 1.223 |
| March 21, 2024 | 1.268 |
| March 20, 2024 | 1.223 |
| March 19, 2024 | 1.170 |
| March 18, 2024 | 1.344 |
| March 15, 2024 | 1.230 |
| March 14, 2024 | 1.306 |
| March 13, 2024 | 1.330 |
| March 12, 2024 | 1.360 |
| March 11, 2024 | 1.390 |
| March 08, 2024 | 1.427 |
| March 07, 2024 | 1.472 |
| March 06, 2024 | 1.482 |
| March 05, 2024 | 1.465 |
| March 04, 2024 | 1.427 |
| March 01, 2024 | 1.517 |
| February 29, 2024 | 1.69 |
| February 28, 2024 | 1.412 |
| February 27, 2024 | 1.480 |
| February 26, 2024 | 1.465 |
| February 23, 2024 | 1.540 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6094
Minimum
Nov 14 2022
7.544
Maximum
Mar 25 2021
2.347
Average
1.871
Median
Jan 31 2022
Price to Book Value Benchmarks
| Fonar Corp | 0.6425 |
| XWELL Inc | 0.5759 |
| ProPhase Labs Inc | 2.094 |
| Applied DNA Sciences Inc | 0.7647 |
| Veracyte Inc | 1.463 |
Price to Book Value Related Metrics
| PS Ratio | 0.471 |
| Price | 1.40 |
| Earnings Yield | -95.71% |
| Market Cap | 24.13M |